6-9 December 2025
67th American Society of Hematology (ASH) Annual Meeting
Orlando
FL
United States
Summary of Abstracts
Abstract Title: “Preliminary safety and efficacy data of the FRIDA study: iadademstat and gilteritinib in FLT3-mutated relapsed/refractory acute myeloid leukemia”
Presenting Author: Dr. Amir Fathi
Type: Poster Presentation
Session Name: 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III
Session Date: December 8, 2025
Presentation Time: 6:00 PM - 8:00 PM EST
Room: OCCC - West Halls B3-B4
Presentation ID: 5197
Abstract Title: “Preliminary safety and efficacy results of a Phase Ib investigation of the LSD1 inhibitor iadademstat (ORY-1001) in combination with azacitidine and venetoclax in newly-diagnosed AML”
Presenting Author: Dr. Curtis Lachowiez
Type: Poster Presentation
Session Name: 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster I
Session Date: December 6, 2025
Presentation Time: 5:30 PM - 7:30 PM EST
Room: OCCC - West Halls B3-B4
Presentation ID: 1649
Abstract Title: “Trial in progress - a randomized study of ASTX727 with or without iadademstat in accelerated/blast-phase myeloproliferative neoplasms”
Presenting Author: Dr. Anand Patel
Type: Poster Presentation
Session Name: 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II
Session Date: December 7, 2025
Presentation Time: 6:00 PM - 8:00 PM EST
Room: OCCC - West Halls B3-B4
Presentation ID: 3827
